The effect of green tea on blood pressure and lipid profile: A systematic review and meta-analysis of randomized clinical trials

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 8, 2014, Pages 823-836

  Onakpoya, I ^a   Spencer, E ^a   Heneghan, C ^a   Thompson, M ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Blood lipid; Blood pressure; Green tea; Meta analysis; Randomized clinical trial

Indexed keywords

CHOLESTEROL; GREEN TEA EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PLANT EXTRACT; TEA; TRIACYLGLYCEROL;

ABDOMINAL DISCOMFORT; ARTICLE; BLOOD PRESSURE MONITORING; CONSTIPATION; DIASTOLIC BLOOD PRESSURE; DYSPEPSIA; ELEVATED BLOOD PRESSURE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; LIFESTYLE MODIFICATION; LIPID ANALYSIS; MERCURY SPHYGMOMANOMETER; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMISTRY; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFECTS; TEA;

ANIMALS; BLOOD PRESSURE; CHOLESTEROL; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TEA; TRIGLYCERIDES;

EID: 84904737100     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.01.016     Document Type: Article

References (82)

1. Chockalingam A., Campbell N.R., Fodor J.G. Can J Cardiol 2006 May, 22(7):553-555. [Worldwide epidemic of hypertension].
2. Kearney P.M., Whelton M., Reynolds K., Whelton P.K., He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004 Jan, 22(1):11-19.
3. Oparil S., Zaman M.A., Calhoun D.A. Pathogenesis of hypertension. Ann Intern Med 2003, 139(9):761-776.
4. Forman J.P., Stampfer M.J., Curhan G.C. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 2009 July 22, 302(4):401-411.
5. Geleijnse J.M., Kok F.J., Grobbee D.E. Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populations. Eur J Public Health 2004, 14(3):235-239.
6. Rasmussen C.B., Glisson J.K., Minor D.S. Dietary supplements and hypertension: potential benefits and precautions. J Clin Hypertens (Greenwich) 2012 Jul, 14(7):467-471.
7. Cheng T.O. All teas are not created equal: the Chinese green tea and cardiovascular health. Int J Cardiol 2006 Apr 14, 108(3):301-308.
8. USDA database for the flavonoid content of Selected foods. Nutrient Data Laboratory. Food Composition Laboratory. Beltsville Human Nutrition Research Center. Nutrient Data Laboratory. United States Department of Agriculture. Available at: [accessed 23.04.13]. http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/Flav/Flav02-1.pdf.
9. Frei B., Higdon J.V. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 2003 Oct, 133(10):3275S-3284S.
10. Khan N., Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007, 81:519-533.
11. Kim E.Y., Ham S.K., Shigenaga M.K., Han O. Bioactive dietary polyphenolic compounds reduce nonheme iron transport across human intestinal cell monolayers. J Nutr 2008, 138(9):1647-1651.
12. Rains T.M., Agarwal S., Maki K.C. Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 2011 Jan, 22(1):1-7.
13. Actis-Goretta L., Ottaviani J.I., Fraga C.G. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem 2006 Jan 11, 54(1):229-234.
14. Guerrero L., Castillo J., Quiñones M., Garcia-Vallvé S., Arola L., Pujadas G., et al. Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies. PLoS ONE 2012, 7(11):e49493. 10.1371/journal.pone.0049493.
15. Ihm S.H., Jang S.W., Kim O.R., Chang K., Oak M.H., Lee J.O., et al. Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome. Atherosclerosis 2012 Oct, 224(2):377-383.
16. Papparella I., Ceolotto G., Montemurro D., Antonello M., Garbisa S., Rossi G., et al. Green tea attenuates angiotensin II-induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway. J Nutr 2008, 138:1596-1601.
17. Lee M.S., Park J.Y., Freake H., Kwun I.S., Kim Y. Green tea catechin enhances cholesterol 7alpha-hydroxylase gene expression in HepG2 cells. Br J Nutr 2008 Jun, 99(6):1182-1185.
18. Annaba F., Kumar P., Dudeja A.K., Saksena S., Gill R.K., Alrefai W.A. Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT. Am J Physiol Gastrointest Liver Physiol 2010 Mar, 298(3):G467-G473.
19. Bursill C.A., Abbey M., Roach P.D. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 2007, 193:86-93.
20. Ikeda I., Imasato Y., Sasaki E., Nakayama M., Nagao H., Takeo T., et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochem Biophys Acta 1992, 1127:141-146.
21. Bursill C.A., Roach P.D. A green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats. Lipids 2007, 42:621-627.
22. Yang Y.C., Lu F.H., Wu J.S., Wu C.H., Chang C.J. The protective effect of habitual tea consumption on hypertension. Arch Intern Med 2004 Jul 26, 164(14):1534-1540.
23. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 2007, 26:S373-S388.
24. Taubert D., Roesen R., Schömig E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med 2007 Apr 9, 167(7):626-634.
25. Ras R.T., Zock P.L., Draijer R. Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis. PLoS One 2011 Mar 4, 6(3):e16974. 10.1371/journal.pone.0016974.
26. Kim A., Chiu A., Barone M.K., Avino D., Wang F., Coleman C.I., et al. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc 2011 Nov, 111(11):1720-1729. 10.1016/j.jada.2011.08.009.
27. Zheng X.X., Xu Y.L., Li S.H., Liu X.X., Hui R., Huang X.H. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr 2011, 94:601-610.
28. Schulz K.F., Altman D.G., Moher D., for the CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PloS Med 2010, 7(3):e1000251.
29. Review manager (RevMan) [Computer Program]. Version 5.0 2008, The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen.
30. Chapter 9: analysing data and undertaking meta-analyses. Cochrane handbook for systematic reviews of interventions version 5.1.0 2011, Deeks JJ, Higgins JPT, Altman DG (editors), (updated March 2011), The Cochrane Collaboration, Available from:. http://www.cochrane-handbook.org, J.P.T. Higgins, S. Green (Eds.).
31. Auvichayapat P., Prapochanung M., Tunkamnerdthai O., Sripanidkulchai B.O., Auvichayapat N., Thinkhamrop B., et al. Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial. Physiol Behav 2008 Feb 27, 93(3):486-491.
32. Boschmann M., Thielecke F. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J Am Coll Nutr 2007 Aug, 26(4):389S-395S.
33. Cardoso G.A., Salgado J.M., Cesar Mde C., Donado-Pestana C.M. The effects of green tea consumption and resistance training on body composition and resting metabolic rate in overweight or obese women. J Med Food 2013, 16(2):120-127.
34. Stendell-Hollis N.R., Thomson C.A., Thompson P.A., Bea J.W., Cussler E.C., Hakim I.A. Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J Hum Nutr Diet 2010 Dec, 23(6):590-600.
35. Yoshikawa T., Yamada H., Matsuda K., Niino H., Sagesaka Y.M., Kakuda T., et al. Effects of short-term consumption of a large amount of tea catechins on chromosomal damage, oxidative stress markers, serum lipid, folic acid, and total homocysteine levels. Jpn J Clin Pharmacol Ther 2012, 43(1):9-16.
36. Basu A., Sanchez K., Leyva M.J., Wu M., Betts N.M., Aston C.E., et al. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr 2010 Feb, 29(1):31-40.
37. Fukino Y., Shimbo M., Aoki N., Okubo T., Iso H. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) 2005 Oct, 51(5):335-342.
38. Fukino Y., Ikeda A., Maruyama K., Aoki N., Okubo T., Iso H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 2008 Aug, 62(8):953-960.
39. Vieira Senger A.E., Schwanke C.H., Gomes I., Valle Gottlieb M.G. Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly. J Nutr Health Aging 2012, 16(9):738-742.
40. Belza A., Toubro S., Astrup A. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur J Clin Nutr 2009 Jan, 63(1):57-64.
41. Hodgson J.M., Puddey I.B., Burke V., Beilin L.J., Jordan N. Effects on blood pressure of drinking green and black tea. J Hypertens 1999 Apr, 17(4):457-463.
42. Smith A.E., Lockwood C.M., Moon J.R., Kendall K.L., Fukuda D.H., Tobkin S.E., et al. Physiological effects of caffeine, epigallocatechin-3-gallate, and exercise inoverweight and obese women. Appl Physiol Nutr Metab 2010 Oct, 35(5):607-616.
43. ChH Tsai, Chiu W.C., Yang N.C., Ouyang C.M., Yen Y.H. A novel green tea meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Int J Food Sci Nutr 2009, 60(Suppl. 6):151-159.
44. Batista Gde A., Cunha C.L., Scartezini M., von der Heyde R., Bitencourt M.G., Melo S.F. Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias. Arq Bras Cardiol 2009 Aug, 93(2):128-134.
45. Bogdanski P., Suliburska J., Szulinska M., Stepien M., Pupek-Musialik D., Jablecka A. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res 2012 Jun, 32(6):421-427.
46. Brown A.L., Lane J., Coverly J., Stocks J., Jackson S., Stephen A., et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr 2009 Mar, 101(6):886-894.
47. Brown A.L., Lane J., Coverly J., Stocks J., Jackson S., Stephen A., et al. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br J Nutr 2009 Mar, 101(6):886-894.
48. Diepvens K., Kovacs E.M., Nijs I.M., Vogels N., Westerterp-Plantenga M.S. Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females. Br J Nutr 2005 Dec, 94(6):1026-1034.
49. Diepvens K., Kovacs E.M., Vogels N., Westerterp-Plantenga M.S. Metabolic effects of green tea and of phases of weight loss. Physiol Behav 2006 Jan 30, 87(1):185-191.
50. Frank J., George T.W., Lodge J.K., Rodriguez-Mateos A.M., Spencer J.P., Minihane A.M., et al. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr 2009 Jan, 139(1):58-62.
51. Hill A.M., Coates A.M., Buckley J.D., Ross R., Thielecke F., Howe P.R. Can EGCG reduce abdominal fat in obese subjects?. J Am Coll Nutr 2007 Aug, 26(4):396S-402S.
52. Hsu C.H., Tsai T.H., Kao Y.H., Hwang K.C., Tseng T.Y., Chou P. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 2008 Jun, 27(3):363-370.
53. Hsu C.H., Liao Y.L., Lin S.C., Tsai T.H., Huang C.J., Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev 2011 Jun, 16(2):157-163.
54. Kajimoto O., Kajimoto Y., Yabune M., Nozawa A., Nagata K., Kakuda T. Tea catechins reduce serum cholesterol levels in mild and borderline hypercholesterolemia patients. J Clin Biochem Nutr 2003, 33(3):101-111.
55. Maki K.C., Reeves M.S., Farmer M., Yasunaga K., Matsuo N., Katsuragi Y., et al. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr 2009 Feb, 139(2):264-270.
56. Matsuyama T., Tanaka Y., Kamimaki I., Nagao T., Tokimitsu I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring) 2008 Jun, 16(6):1338-1348.
57. Nagao T., Hase T., Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 2007 Jun, 15(6):1473-1483.
58. Nagao T., Meguro S., Hase T., Otsuka K., Komikado M., Tokimitsu I., et al. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring) 2009 Feb, 17(2):310-317.
59. Nantz M.P., Rowe C.A., Bukowski J.F., Percival S.S. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition 2009 Feb, 25(2):147-154.
60. Sone T., Kuriyama S., Nakaya N., Hozawa A., Shimazu T., Nomura K., et al. Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr Res 2011, 55. 10.3402/fnr.v55i0.8326.
61. Suliburska J., Bogdanski P., Szulinska M., Stepien M., Pupek-Musialik D., Jablecka A. Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res 2012 Dec, 149(3):315-322.
62. Takase H., Nagao T., Otsuka K., Meguro S., Komikado M., Tokimitsu I. Effects of long-term ingestion of tea catechins on visceral fat accumulation and metabolic syndrome risk in women with abdominal obesity. Jpn Pharmacol Ther 2008, 36(3):237-245.
63. Takeshita M., Takashima S., Harada U., Shibata E., Hosoya N., Takase H., et al. Effects of long-term consumption of tea catechins-enriched beverage with no caffeine on body composition in humans. Jpn Pharmacol Ther 2008, 36:767-776.
64. Widlansky M.E., Hamburg N.M., Anter E., Holbrook M., Kahn D.F., Elliott J.G., et al. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 2007 Apr, 26(2):95-102.
65. Hartley L., Flowers N., Holmes J., Clarke A., Stranges S., Hooper L., et al. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013, (6). Art. No.: CD009934. 10.1002/14651858.CD009934.pub2.
66. Yokozawa T., Oura H., Sakanaka S., Ishigaki S., Kim M. Depressor effect of tannin in green tea on rats with renal hypertension. Biosci Biotechnol Biochem 1994, 58:855-858.
67. August D.A., Landau J., Caputo D., Hong J., Lee M.J., Yang C.S. Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiol Biomarkers Prev 1999 Aug, 8(8):709-713.
68. Rutkai I., Feher A., Erdei N., Henrion D., Papp Z., Edes I., et al. Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes. Cardiovasc Res 2009, 83:148-154.
69. Overlack A., Stumpe K.O., Ressel C., Krück F. Low urinary kallikrein excretion and elevated blood pressure normalized by orally kallikrein in essential hypertension. Clin Sci (Lond) 1979 Dec, 57(Suppl. 5):263s-265s.
70. Abe Y., Umemura S., Sugimoto K., Hirawa N., Kato Y., Yokoyama N., et al. Effect of green tea rich in gamma-aminobutyric acid on blood pressure of Dahl salt-sensitive rats. Am J Hypertens 1995, 8:74-79.
71. Yoshimura M., Toyoshi T., Sano A., Izumi T., Fujii T., Konishi C., et al. Antihypertensive effect of a gamma-aminobutyric acid rich tomato cultivar 'DG03-9' in spontaneously hypertensive rats. J Agric Food Chem 2010 Jan 13, 58(1):615-619.
72. Inoue K., Shirai T., Ochiai H., Kasao M., Hayakawa K., Kimura M., et al. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 2003 Mar, 57(3):490-495.
73. Koga T., Meydani M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr 2001, 73:941-948.
74. Yang Y.J., Kim Y.J., Yang Y.K., Kim J.Y., Kwon O. Dietary flavan-3-ols intake and metabolic syndrome risk in Korean adults. Nutr Res Pract 2012 Feb, 6(1):68-77.
75. Mazzanti G., Menniti-Ippolito F., Moro P.A., Cassetti F., Raschetti R., Santuccio C., et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009, 65(4):331-341.
76. Suganuma M., Okabe S., Oniyama M., Tada Y., Ito H., Fujiki H. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998, 19(10):1771-1776.
77. Yang C.S., Chen L., Lee M.J., Balentine D., Kuo M.C., Schantz S.P. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 1998, 7(4):351-354.
78. Schmidt M., Schmitz H.J., Baumgart A., Guédon D., Netsch M.I., Kreuter M.H., et al. Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture. Food Chem Toxicol 2005, 43(2):307-314.
79. Sarma D.N., Barrett M.L., Chavez M.L., Gardiner P., Ko R., Mahady G.B., et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf 2008, 31(6):469-484.
80. Chen J.H., Tipoe G.L., Liong E.C., So H.S., Leung K.M., Tom W.M., et al. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr 2004, 80(3):742-751.
81. Skrzydlewska E., Ostrowska J., Farbiszewski R., Michalak K. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine 2002 Apr, 9(3):232-238.
82. Chow H.H., Cai Y., Hakim I.A., Crowell J.A., Shahi F., Brooks C.A., et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003, 9(9):3312-3319.